Alvotech ALVO

About Alvotech (ALVO): stock profile, AI score and financials

Alvotech (ALVO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ALVO is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), Alvotech reports quarterly revenue of $586.3M, net income of $27.9M, an operating margin of 13.3%. Top institutional holders of ALVO by reported 13-F value include Rubric Capital Management, MILLENNIUM MANAGEMENT, Bracebridge Capital, based on the most recent SEC filings. ALVO trades on the Nasdaq exchange and files with the SEC under CIK 1898416. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALVO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alvotech directly from SEC EDGAR.

SEC EDGAR: CIK 1898416 →